Moreover, recent studies demonstrated that SLC1A5 expression was positively and significantly associated with the abundance of tumor-infiltrating immune cells in stomach adenocarcinoma (STAD) and HCC (Zhao et al., 2021; Zhu et al., 2022). This evidence concerns the gene SLC1A5 and hepatocellular carcinoma.